Jason Drew Smith, General Counsel: UroGen Pharma URGN Sell · Filed 25/07/30

Trade details

Type: Insider sale
Amount: $143,971.08
Shares · price: 7,522 sh · $19.14 a share
Held after: 41,492 sh
Stock: UroGen Pharma URGN
Person: Jason Drew SmithGeneral Counsel
Trade date: 25/07/28
Filed: 25/07/30
Days to filing: 2 days

Sold 15.3% of holdings

Share of holding sold: 15.3%

UroGen Pharma trades, last 26 weeks

What else happened in UroGen Pharma around then

Filed or reported within 30 days of the trade day · 25/06/28~25/08/27

Jason Drew Smith's recent trades

Jason Drew SmithGeneral Counsel
Planned saleUroGen Pharma
Planned sale
UroGen Pharma
URGN
$67K
1,519 sh
$67K
Filed 09/09
Traded 09/08
Jason Drew SmithGeneral Counsel
SellUroGen Pharma
Sell
UroGen Pharma
URGN
$63.3K
3,217 sh
$63.3K
Filed 02/11
Traded 02/03
Jason Drew SmithGeneral Counsel
SellUroGen Pharma
Sell
UroGen Pharma
URGN
$52.3K
2,654 sh
$52.3K
Filed 02/11
Traded 02/03
Jason Drew SmithGeneral Counsel
SellUroGen Pharma
Sell
UroGen Pharma
URGN
$31.7K
1,608 sh
$31.7K
Filed 02/11
Traded 02/03
Jason Drew SmithGeneral Counsel
SellUroGen Pharma
Sell
UroGen Pharma
URGN
$29K
1,520 sh
$29K
Filed 25/09/09
Traded 25/09/08